# Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer

> **NCT00653757** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** goserelin acetate
- **DRUG:** leuprolide acetate
- **RADIATION:** image-guided radiation therapy
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00653757
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2006-12
- **Final completion:** 2007-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653757, "Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00653757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*